These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3456607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human lysosomal alpha-glucosidase. Characterization of the catalytic site.
    Hermans MM, Kroos MA, van Beeumen J, Oostra BA, Reuser AJ.
    J Biol Chem; 1991 Jul 25; 266(21):13507-12. PubMed ID: 1856189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
    Kuo CL, Kallemeijn WW, Lelieveld LT, Mirzaian M, Zoutendijk I, Vardi A, Futerman AH, Meijer AH, Spaink HP, Overkleeft HS, Aerts JMFG, Artola M.
    FEBS J; 2019 Feb 25; 286(3):584-600. PubMed ID: 30600575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S, Dinur T, Osiecki K, Desnick RJ, Grabowski GA.
    Enzyme; 1985 Feb 25; 33(2):109-19. PubMed ID: 3924590
    [Abstract] [Full Text] [Related]

  • 9. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
    Grace ME, Graves PN, Smith FI, Grabowski GA.
    J Biol Chem; 1990 Apr 25; 265(12):6827-35. PubMed ID: 2324100
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.
    Newburg DS, Shea TB, Yatziv S, Raghavan SS, McCluer RH.
    Exp Mol Pathol; 1988 Jun 25; 48(3):317-23. PubMed ID: 3371456
    [Abstract] [Full Text] [Related]

  • 14. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
    Grabowski GA, Gatt S, Kruse J, Desnick RJ.
    Arch Biochem Biophys; 1984 May 15; 231(1):144-57. PubMed ID: 6426391
    [Abstract] [Full Text] [Related]

  • 15. Gaucher disease: a membranous enzymopathy.
    Desnick RJ, Grabowski GA, Dinur T, Fabbro D, Goldblatt J, Gatt S.
    Prog Clin Biol Res; 1982 May 15; 97():193-215. PubMed ID: 6818558
    [Abstract] [Full Text] [Related]

  • 16. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A, Salvayre R, Samadi M, Douste-Blazy L.
    Enzyme; 1987 May 15; 37(4):208-17. PubMed ID: 3038513
    [Abstract] [Full Text] [Related]

  • 17. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.
    Legler G, Bieberich E.
    Arch Biochem Biophys; 1988 Jan 15; 260(1):437-42. PubMed ID: 3124752
    [Abstract] [Full Text] [Related]

  • 18. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.
    Grabowski GA, Gatt S, Horowitz M.
    Crit Rev Biochem Mol Biol; 1990 Jan 15; 25(6):385-414. PubMed ID: 2127241
    [Abstract] [Full Text] [Related]

  • 19. Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting.
    Fabbro D, Desnick RJ, Grabowski GA.
    Am J Hum Genet; 1987 Jan 15; 40(1):15-31. PubMed ID: 3812484
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
    van Weely S, Brandsma M, Strijland A, Tager JM, Aerts JM.
    Biochim Biophys Acta; 1993 Mar 24; 1181(1):55-62. PubMed ID: 8457606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.